IMPACT FACTOR
1.4
|
MNiSW
70
|
JCI
0.32
Journal Citation Indicator
|
CiteScore 2022
2.5
|
Journal of Contemporary Brachytherapy is indexed in:
Directory of Open Access Journals (DOAJ), EMBASE, Free Medical Journals, Geneva Foundation Free Medical Journals, HINARI Access to Research, International Committee of Medical Journal Editors (ICMJE), Index Copernicus, ISI Master Journal List, ISI Science Citation Index Expanded (SCI-Ex), Polish Minsitry of Science and Higher Education (PMSHE), PubMed, PubMed Central, Polish Medical Library (GBL), SCIRUS, SCOPUS, WorldCat
Journal integrated with
4/2022
vol. 14
|
|
Editorial
Letter from the Editor-in-Chief
Adam Chicheł
Online publish date: 2022-08-31
Original paper
An Asian multi-national, multi-institutional, retrospective study on image-guided brachytherapy in cervical adenocarcinoma and adenosquamous carcinoma
Noriyuki Okonogi,
Naoya Murakami,
Ken Ando,
Masumi Murata,
Kazutoshi Murata,
Tomomi Aoshika,
Shingo Kato,
Anneyuko I Saito,
Joo-Young Kim,
Yasuo Yoshioka,
Shuhei Sekii,
Kayoko Tsujino,
Chairat Lowanichkiattikul,
Poompis Pattaranutaporn,
Yuko Kaneyasu,
Tomio Nakagawa,
Miho Watanabe,
Takashi Uno,
Rei Umezawa,
Keiichi Jingu,
Ayae Kanemoto,
Masaru Wakatsuki,
Katsuyuki Shirai,
Hiroshi Igaki,
Tatsuya Ohno,
Jun Itami
J Contemp Brachytherapy 2022; 14, 4: 311–320
Online publish date: 2022-08-31
DOI
:
https://doi.org/10.5114/jcb.2022.119451
Original paper
Early clinical outcomes of hybrid brachytherapy
for locally advanced cervical cancer: making adverse situations in a favorable scenario
Leonel Varela Cagetti,
Christophe Zemmour,
Eric Lambaudie,
Magalie Provansal,
Renaud Sabatier,
Laura Sabiani,
Guillaume Blache,
Camille Jauffret,
Marjorie Ferré,
Agnès Tallet,
Laurence Gonzague
J Contemp Brachytherapy 2022; 14, 4: 321–331
Online publish date: 2022-08-17
DOI
:
https://doi.org/10.5114/jcb.2022.118831
Original paper
Prognostic factors for IB2-IIIB cervical cancer patients treated by radiation therapy with high-dose-rate brachytherapy in a single-institution study
Yu-Ting Xiu,
Fan-Xu Meng,
Zhuo Wang,
Kang-Kang Zhao,
Yun-Long Wang,
Zhi-Shen Chen,
Bao-Sheng Sun
J Contemp Brachytherapy 2022; 14, 4: 332–340
Online publish date: 2022-08-09
DOI
:
https://doi.org/10.5114/jcb.2022.118674
Original paper
Quality of life and sexual functioning among endometrial cancer patients treated with one week adjuvant high-dose-rate vaginal brachytherapy schedule
Giuseppe Facondo,
Gianluca Vullo,
Vitaliana De Sanctis,
Cecilia Vitiello,
Luciano Nieddu,
Marco Alfò,
Claudia Scaringi,
Francesca De Felice,
Margherita Rotondi,
Flavia De Giacomo,
Ilary Ruscito,
Maurizio Valeriani,
Mattia Falchetto Osti
J Contemp Brachytherapy 2022; 14, 4: 341–346
Online publish date: 2022-08-31
DOI
:
https://doi.org/10.5114/jcb.2022.119198
Original paper
Brachytherapy dose changes: comparing in-room and out-room image-guided brachytherapy. A randomized study
Pooriwat Muangwong,
Ekkasit Tharavichitkul,
Patumrat Sripan,
Somvilai Chakrabandhu,
Pitchayaponne Klunklin,
Wimrak Onchan,
Bongkot Jia-Mahasap,
Razvan Galalae,
Imjai Chitapanarux
J Contemp Brachytherapy 2022; 14, 4: 347–353
Online publish date: 2022-08-19
DOI
:
https://doi.org/10.5114/jcb.2022.118940
Original paper
Control charts for evaluation of quality of low-dose-rate brachytherapy for prostate cancer
Nicola J. Nasser,
Elantholi P. Saibishkumar,
Yinkun Wang,
Peter W.M. Chung,
Stephen L. Breen
J Contemp Brachytherapy 2022; 14, 4: 354–363
Online publish date: 2022-08-31
DOI
:
https://doi.org/10.5114/jcb.2022.119513
Original paper
Sarcopenia does not limit overall survival after interstitial brachytherapy for breast cancer liver metastases
Maximilian Thormann,
Franziska Heitmann,
Christine March,
Maciej Pech,
Peter Hass,
Alexey Surov,
Robert Damm,
Jazan Omari
J Contemp Brachytherapy 2022; 14, 4: 364–369
Online publish date: 2022-08-31
DOI
:
https://doi.org/10.5114/jcb.2022.119515
Original paper
Narrowing the difference in dose delivery for IOERT and IOBT for locally advanced and locally recurrent rectal cancer
An-Sofie E. Verrijssen,
Wim J.F. Dries,
Jeltsje S. Cnossen,
Jacqueline Theuws,
Heike M.U. Peulen,
Hetty A. van den Berg,
Dorien C. Rijkaart,
Eva L.K. Voogt,
Inger-Karine Kolkman-Deurloo,
Joost Nuyttens,
Harm J.T. Rutten,
Jacobus W.A. Burger,
Cathryn Huibregtse Bimmel-Nagel
J Contemp Brachytherapy 2022; 14, 4: 370–378
Online publish date: 2022-07-21
DOI
:
https://doi.org/10.5114/jcb.2022.118305
Original paper
Patient safety program and incident review of high-dose-rate brachytherapy at an academic center in Thailand
Lalida Tuntipumiamorn,
Kanitta Kamplong,
Bhuvadol Pengchantr,
Kantarat Rojanapan,
Porntip Iampongpaiboon,
Yaowalak Chansilpa
J Contemp Brachytherapy 2022; 14, 4: 390–397
Online publish date: 2022-08-17
DOI
:
https://doi.org/10.5114/jcb.2022.118793
Original paper
Dosimetric comparison of two afterloaders and treatment planning systems in vaginal high-dose-rate brachytherapy
Deborah C. Marshall,
Julie R. Bloom,
Zahra Ghiassi-Nejad,
Vishal Gupta,
Audrey Saitta,
Allison Powers,
Ren-Dih Sheu,
Yeh-Chi Lo,
Vishruta Dumane
J Contemp Brachytherapy 2022; 14, 4: 398–402
Online publish date: 2022-08-08
DOI
:
https://doi.org/10.5114/jcb.2022.118633
Review paper
Prediction models for brachytherapy-induced rectal
toxicity in patients with locally advanced pelvic
cancers: a systematic review
Fariba Tohidinezhad,
Yves Willems,
Maaike Berbee,
Evert Van Limbergen,
Frank Verhaegen,
Andre Dekker,
Alberto Traverso
J Contemp Brachytherapy 2022; 14, 4: 411–422
Online publish date: 2022-08-31
DOI
:
https://doi.org/10.5114/jcb.2022.119427
|
|
